Liquidia Corp (LQDA) - Dilution Analysis

10-Q filing | 86.3M shares outstanding

10-Q filing | 85.6M shares outstanding

10-Q filing | 85.2M shares outstanding

10-K filing | 68.6M shares outstanding

S-3 filing: Liquidia Corporation files an S-3 to register the resale of up to 1,123,595 shares of common stock by selling stockholders.

10-Q filing | 78.3M shares outstanding

8-K filing: Liquidia Corporation completed a private placement of 1,123,595 shares at $8.90 per share for $10.0 million and a public offering of 6,460,674 shares at $8.90 per share for $57.5 million on September 12, 2024. ($67.5M proceeds)

8-K filing: Liquidia Corporation entered into an underwriting agreement for a public offering of 6,460,674 shares at $8.90 per share and a purchase agreement for a private placement of 1,123,595 shares at $8.90 per share, expected to close on September 12, 2024. ($67.5M proceeds)

10-Q filing | 76.4M shares outstanding

S-3 filing: This S-3 filing registers 7,322,197 shares of common stock for resale by selling stockholders.

10-Q filing | 75.4M shares outstanding

10-K filing | 65.0M shares outstanding

8-K filing: Liquidia Corporation completed a private placement on January 8, 2024, selling 7,182,532 shares of common stock to Legend Aggregator, LP at a price of $10.442 per share, resulting in gross proceeds of approximately $75.0 million. ($75.0M proceeds)

8-K filing: Liquidia Corporation entered into a Common Stock Purchase Agreement with Legend Aggregator, LP for the sale of 7,182,532 shares of common stock at a price of $10.442 per share in a private placement. ($75.0M proceeds)

S-3/A filing: Liquidia Corporation files an S-3/A registration statement to offer up to $200,000,000 of common stock, preferred stock, debt securities, warrants, or units.

S-3 filing: Liquidia Corporation files an S-3 registration statement to offer up to $200,000,000 of common stock, preferred stock, debt securities, warrants and units.

8-K filing: Liquidia Corporation completed a private placement of 139,665 shares of common stock to Roger Jeffs, the CEO, at $7.16 per share, and a public offering of 3,491,620 shares of common stock at $7.16 per share. ($26.0M proceeds)

8-K filing: Liquidia Corporation entered into an underwriting agreement for a public offering of 3,491,620 shares at $7.16 per share and a concurrent private placement with its CEO for 139,665 shares at $7.16 per share. ($26.0M proceeds)

10-Q filing | 64.9M shares outstanding

10-Q filing | 64.8M shares outstanding

10-Q filing | 64.7M shares outstanding

10-K filing | 61.0M shares outstanding

10-Q filing | 64.5M shares outstanding

10-Q filing | 62.2M shares outstanding

8-K filing: Rajeev Saggar, M.D., was appointed as the Company's Chief Medical Officer effective July 18, 2022, and will receive a stock option for 200,000 shares of common stock and restricted stock units equal to $350,000.00 divided by the Fair Market Value of a share of the Company's Common Stock.

10-Q filing | 52.5M shares outstanding

8-K filing: Liquidia Corporation completed an underwritten registered public offering of 11,274,510 shares of common stock at a price of $5.10 per share, resulting in net proceeds of approximately $53.7 million. ($57.5M proceeds)

10-K filing | 49.7M shares outstanding

8-K filing: Liquidia Corporation entered into an Amended and Restated Loan and Security Agreement providing up to $40.0 million in term loans and issued warrants to SVB, Innovation, and Innovation Credit to purchase shares of the Company's common stock at an exercise price of $5.14 per share.

10-Q filing | 52.0M shares outstanding

S-3 filing: This S-3 filing relates to the resale of 8,626,037 shares of common stock by selling stockholders; the company will not receive any proceeds from the sale.

10-Q filing | 52.0M shares outstanding

10-Q filing | 52.0M shares outstanding

8-K filing: Liquidia Corporation entered into a Common Stock Purchase Agreement with Caligan Partners LP and other accredited investors for the sale of 8,626,037 shares of common stock at $2.52 per share, resulting in gross proceeds of approximately $21.7 million. ($21.7M proceeds)

8-K filing: Liquidia Corporation granted non-qualified stock options to its non-employee directors in lieu of cash compensation for fiscal year 2021, with an exercise price of $2.51 per share and a vesting schedule.

10-K filing | 43.3M shares outstanding

8-K filing: Liquidia Corporation entered into a Loan and Security Agreement with Silicon Valley Bank, establishing a term loan facility of up to $20.5 million and issued a warrant to purchase up to 200,000 shares of common stock.

S-3/A filing: This is an S-3/A filing related to the registration of common stock, where underwriters will agree to indemnify the company and its directors/officers against certain liabilities. It also includes undertakings to file post-effective amendments during the offering period.

S-3 filing: Liquidia Technologies files an S-3 registration statement for the potential offering of common stock, preferred stock, debt securities, warrants and units, with a total aggregate amount of $200,000,000. Additionally, registers 16,039,533 shares of common stock for resale by selling stockholders.